Clinical Trial Update: Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Hib-MenCY-TT vaccine compared with licensed Hib and meningococcal serogroup C vaccines; study completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Infection
• Meningococcal Disease

Drugs mentioned

• Hib-MenCY-TT vaccine (Haemophilus influenzae type b meningococcal serogroups C and Y tetanus toxoid conjugate vaccine)
• Licensed Hib vaccine (Haemophilus influenzae type b conjugate vaccine)
• Meningococcal serogroup C conjugate vaccine (Neisseria meningitidis serogroup C conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neisseria Meningitidis, Haemophilus Influenzae Type b | Phase 2 | Status: COMPLETED | Results posted: 2012-07-20